计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab170882-100μg |
100μg |
现货 ![]() |
| |
| Ab170882-1mg |
1mg |
现货 ![]() |
| |
| Ab170882-5mg |
5mg |
现货 ![]() |
| |
| Ab170882-10mg |
10mg |
期货 ![]() |
|
| 产品名称 | Eldelumab (anti-CXCL10), C-X-C 矩阵趋化因子 10 抑制剂 |
|---|---|
| 别名 | 埃迪鲁单抗 | 埃代鲁单抗(抗 CXCL10) |
| 英文别名 | Interferon gamma induced factor MOB1, mouse, homolog of antibody | Interferon gamma induced protein 10 antibody | 10 kDa interferon gamma induced protein antibody | 10 kDa interferon gamma-induced protein antibody | C X C motif chemokine 10 antibody | C7 |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | CXCL10 |
| 种属反应性 | 人(Human),恒河猴(Rhesus monkey) |
| 偶联 | Unconjugated |
| 作用类型 | 抑制剂 |
| 作用机制 | C-X-C 矩阵趋化因子 10 抑制剂 |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG1 |
| 轻链亚型 | kappa |
| SDS-PAGE | 27.1 kDa (Light Chain) & 53.9 kDa (Heavy Chain), under reducing conditions; 182.8 kDa, under non-reducing conditions. |
| 纯化方法 | Protein A purified |
| 纯度 | >95% |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0. |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| CAS编号和信息 | 946414-98-8 |
| 分子类型 | 抗体 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
Eldelumab (anti-CXCL10) (Ab170882) - SEC
The purity of Eldelumab (anti-CXCL10) (Ab170882) is more than 95% verified by HPLC.
Eldelumab (anti-CXCL10) (Ab170882) - ELISA
Immobilized Recombinant Human CXCL10/IP-10 Protein (rp170434) at 1.0 μg/mL can bind Eldelumab (anti-CXCL10) (Ab170882) with the EC₅₀ of 268.7 ng/mL.
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | Ab170882 | |
| 分析证书 | Ab170882 | |
| 分析证书 | Ab170882 | |
| 分析证书 | Ab170882 | |
| 分析证书 | Ab170882 |
¥669.90
| 1. Loos T, Mortier A, Gouwy M, Ronsse I, Put W, Lenaerts JP, Van Damme J, Proost P. (2008) Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation.. Blood, 112 (7): (2648-56). [PMID:18645041] |
| 2. Luster, A D AD, Unkeless, J C JC and Ravetch, J V JV.. (1985) Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins.. Nature, [PMID:3925348] |
| 3. Angiolillo, A L AL and 8 more authors.. (1995) Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.. The Journal of experimental medicine, (1): [PMID:7540647] |
| 4. Proost, P P and 5 more authors.. (1993) Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8.. Journal of immunology (Baltimore, Md. : 1950), (1): [PMID:8423327] |
| 5. Loetscher, M M and 7 more authors.. (1996) Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes.. The Journal of experimental medicine, (1): [PMID:9064356] |
| 6. Tensen, C P CP and 8 more authors.. (1999) Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3).. The Journal of investigative dermatology, [PMID:10233762] |
| 7. Romagnani, P P and 12 more authors.. (2001) Interferon-inducible protein 10, monokine induced by interferon gamma, and interferon-inducible T-cell alpha chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) alphabeta+ CD8+ single-positive T cells, TCRgammadelta+ T cells, and natural killer-type cells in human thymus.. Blood, (1): [PMID:11157474] |
| 8. Hensbergen, P J PJ and 8 more authors.. (2001) Processing of natural and recombinant CXCR3-targeting chemokines and implications for biological activity.. European journal of biochemistry, [PMID:11559369] |
| 9. Booth, Valerie V, Keizer, David W DW, Kamphuis, Monique B MB, Clark-Lewis, Ian I and Sykes, Brian D BD.. (2002) The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions.. Biochemistry, (20): [PMID:12173928] |
| 10. Cheeran, Maxim C-J MC, Hu, Shuxian S, Sheng, Wen S WS, Peterson, Phillip K PK and Lokensgard, James R JR.. (2003) CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10.. Journal of virology, [PMID:12663757] |
| 11. Swaminathan, G Jawahar GJ and 6 more authors.. (2003) Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine.. Structure (London, England : 1993), [PMID:12737818] |
| 12. Smit, Martine J MJ and 6 more authors.. (2003) CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase.. Blood, (15): [PMID:12750173] |
| 13. Casrouge, Armanda A and 11 more authors.. (2011) Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.. The Journal of clinical investigation, [PMID:21183794] |
| 14. Sidahmed, Abubaker M E AM and 6 more authors.. (2012) CXCL10 contributes to p38-mediated apoptosis in primary T lymphocytes in vitro.. Cytokine, [PMID:22652417] |
| 15. Han, Xuesheng X and Parker, Tory L TL.. (2017) Anti-inflammatory activity of clove (Eugenia caryophyllata) essential oil in human dermal fibroblasts.. Pharmaceutical biology, [PMID:28407719] |